Literature DB >> 15872292

Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.

Rodrigo Alonso1, Estibaliz Mateo, Marc Galimand, Javier Garaizar, P Courvalin, Ramón Cisterna.   

Abstract

Twenty-four community isolates of Streptococcus pyogenes resistant to ciprofloxacin and susceptible to levofloxacin, gatifloxacin, and moxifloxacin were studied. Sequence determination of the quinolone resistance-determining regions in the gyrA and parC genes revealed a T/G mutation in parC leading to a Ser79Ala substitution in ParC. All isolates were of the emm type 6, and 18 and 2 of them were indistinguishable or closely related, respectively, on the basis of pulsed-field gel electrophoresis.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15872292      PMCID： PMC1153807          DOI： 10.1128/JCM.43.5.2492-2493.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus.

Authors:  M Boos; S Mayer; A Fischer; K Köhrer; S Scheuring; P Heisig; J Verhoef; A C Fluit; F J Schmitz
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.

Authors:  Rodrigo Alonso; Marc Galimand; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.

Authors:  Alan L Bisno; Michael A Gerber; Jack M Gwaltney; Edward L Kaplan; Richard H Schwartz
Journal:  Clin Infect Dis       Date:  2002-07-15       Impact factor: 9.079

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases.

Authors:  S Chatellier; N Ihendyane; R G Kansal; F Khambaty; H Basma; A Norrby-Teglund; D E Low; A McGeer; M Kotb
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.

Authors:  E Pérez-Trallero; C Fernández-Mazarrasa; C García-Rey; E Bouza; L Aguilar; J García-de-Lomas; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  A multidrug efflux phenotype mutant of Streptococcus pyogenes.

Authors:  H E Jones; N P Brenwald; K A Owen; M J Gill
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

9.  Fluoroquinolone resistance in Streptococcus pyogenes.

Authors:  Sandra S Richter; Daniel J Diekema; Kris P Heilmann; Laurel S Almer; Virginia D Shortridge; Rod Zeitler; Robert K Flamm; Gary V Doern
Journal:  Clin Infect Dis       Date:  2003-01-14       Impact factor: 9.079

10.  Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes.

Authors:  Sylvain Godreuil; Marc Galimand; Guy Gerbaud; Christine Jacquet; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more
  5 in total

1.  Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

Authors:  Renato Pires; Carmen Ardanuy; Dora Rolo; Ana Morais; António Brito-Avô; José Gonçalo-Marques; Josefina Liñares; Ilda Santos-Sanches
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

Review 2.  Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance.

Authors:  Rob J L Willems; William P Hanage; Debra E Bessen; Edward J Feil
Journal:  FEMS Microbiol Rev       Date:  2011-07-04       Impact factor: 16.408

3.  Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.

Authors:  Milagrosa Montes; Esther Tamayo; Beatriz Orden; Julián Larruskain; Emilio Perez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

4.  An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

Authors:  S Steve Yan; Paul C Schreckenberger; Xiaotian Zheng; Nancy A Nelson; Susan M Harrington; Joyce Tjhio; Daniel P Fedorko
Journal:  Diagn Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 2.803

5.  Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.

Authors:  Lorenzo Aguilar; María-José Giménez; José Barberán
Journal:  Infect Drug Resist       Date:  2010-06-18       Impact factor: 4.003
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.